Table 3.
Proinflammatory cytokines at 3 months of treatment with biological agents and Wilcoxon signed rank test results between 3 months and start of therapy (statistical significance was considered for p < 0.05).
TNF-α at 3 Months (pg/mL) |
IL-23 at 3 Months (pg/mL) |
IL-17A at 3 Months (pg/mL) |
IL-17F at 3 Months (pg/mL) |
|
---|---|---|---|---|
Mean | 26.04 | 88.54 | 41.52 | 48.53 |
Quartile 25 | 18.2 | 60.6 | 35.7 | 43 |
Median | 19.4 | 67.2 | 39 | 47 |
Quartile 75 | 23.8 | 71 | 48.7 | 53 |
Min | 17.2 | 20.6 | 33 | 37 |
Max | 78 | 466.8 | 66.3 | 65 |
Standard deviation | 15.66 | 88.18 | 8.38 | 6.81 |
Standard Error | 3.264583129 | 18.38710243 | 1.747484383 | 1.420844384 |
95% Confidence | [19.6450049, 32.4419351]. | [52.5028037, 124.5789163]. | [24.5500323, 58.4847477]. | [45.7499763, 51.3195837]. |
Average of differences | −4.38 | −22.23 | −2.11 | −2.587 |
Z | −1.83 | −4.53 | −0.81 | −1.65 |
r | −0.38 | −0.94 | −0.17 | −0.36 |
p | 0.068 | <0.000 | 0.417 | 0.098 |